PTS 3E

The PTS3E is designed for the manual control of suppository and pessary disintegration time. It conforms to the current requirements as laid down in the European Pharmacopoeia EP . Three samples are tested simultaneously over a user selectable, pre-set period of 1 minute to 10 hours. The sample containers are rotated through 180 degree, as specified in the monograph. The water bath has a capacity of 12 litres (4ltr. for each of the samples). The total rotation time (for 180 degree) is normally 10 minutes, and the normal disintegration time is approximately 30 minutes. The bath, sample holder and test baskets can be removed from the instrument for cleaning. Due to the thermostat design (circulates from the bottom of the bath) it is made sure that no suppository material arrives inside the heating system.

Display : LED Display
Keyboard : Function Keys
Thermostat : Built-in 1000W heater and circulation pump, temperature adjustable 30 to 40oC
Accuracy : +/- 0.5oC
Testing time : Programmable from 1 minute to 10 hours
Cycling time : Programmable from 1 to 10 minutes
Test stations : 3
Material : Stainless steel to comply with GLP standards

Source : pharma-test.de

About Us

PT. Pharma Test Indonesia was established at the end of 2009. We are the subsidiary of Pharma Test AG (Germany) in South East Asia which supplies machines for Pharmaceutical Industry. As a part of Pharma Test commitment to Indonesian market, the company was established to fulfill the need for high quality testing equipments and supported with excellent after-sales service. Our company also supported the Pharma Test agents in South East Asia especially for the technical support.

Readmore

Contact Us

Anda bisa menghubungi kami untuk lebih detail terkait produk dan layanan kami.

PT. Pharma Test Indonesia
Rukan Crown Blok A No.8
Green Lake City
Tangerang 15147
Indonesia

Phone: +6221 54318816
Mobile. +62 851 00902797

Marketing: hans@pharma-test-indo.com
Technical Support: teknik@pharma-test-indo.com

Newsletter

Subscribe to our newsletter to get latest updates from us.